Literature DB >> 6198311

Painful bone metastasis: efficacy of radiotherapy assessed by the patients: a randomized trial comparing 4 Gy X 6 versus 10 Gy X 2.

E L Madsen.   

Abstract

Fifty-seven patients with painful bone metastases were randomized to receive 4 Gy in 6 fractions over 3 weeks with 2 fractions per week or 10 Gy in 2 fractions with an interval of one week. Pain intensity was assessed by scoring the consumption of analgesics combined with patient self-evaluation on a visual analogue scale. Treatment results were identical in the two treatment groups, with satisfactory pain control in about 48% of the patients. In other studies with physician evaluation of pain control, better results have invariably been reported, suggesting some degree of observer bias. A review of the literature as well as the results of this study indicates that within wide ranges no optimal radiation schedule or dose exist for reducing pain in bone metastases. Therefore short courses of treatment using moderate doses should be preferred for the convenience of the patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6198311     DOI: 10.1016/0360-3016(83)90343-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

1.  Prostate cancer: 10. Palliative care.

Authors:  N A Iscoe; E Bruera; R C Choo
Journal:  CMAJ       Date:  1999-02-09       Impact factor: 8.262

Review 2.  WITHDRAWN: Radiotherapy for the palliation of painful bone metastases.

Authors:  Henry J McQuay; Sally L Collins; Dawn Carroll; R Andrew Moore; Sheena Derry
Journal:  Cochrane Database Syst Rev       Date:  2013-11-22

3.  A survey of patterns of practice on palliative radiation therapy for bone metastasis in Korea.

Authors:  Yoonsun Chung; Woong Sub Koom; Yong Chan Ahn; Hee-Chul Park; Hak Jae Kim; Sang Min Yoon; Sangjin Shin; Yoon Jae Lee
Journal:  J Cancer Res Clin Oncol       Date:  2013-10-10       Impact factor: 4.553

Review 4.  Causes and treatment of bone pain of malignant origin.

Authors:  B Thürlimann; N D de Stoutz
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

5.  Patterns of practice in the prescription of palliative radiotherapy for the treatment of bone metastases at the Rapid Response Radiotherapy Program between 2005 and 2012.

Authors:  N Thavarajah; L Zhang; K Wong; G Bedard; E Wong; M Tsao; C Danjoux; E Barnes; A Sahgal; K Dennis; L Holden; N Lauzon; E Chow
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

6.  Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).

Authors:  Kenneth V Honn; Amer Aref; Yong Q Chen; Michael L Cher; John D Crissman; Jeffrey D Forman; Xiang Gao; David Grignon; Maha Hussain; Arthur T Porter; Edson J Pontes; Bruce Redman; Wael Sakr; Richard Severson; Dean G Tang; David P Wood
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

7.  Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study.

Authors:  Lale Atahan; Ferah Yildiz; Mustafa Cengiz; Bunyamin Kaplan; Metin Ozkan; Gozde Yazici; Mete Gündoğ; Ayfer Haydaroğlu; Aylin F Korcum; Meriç Sengöz; Maktav Dinçer; Müge Akmansu; Kayihan Engin; Mutlu Hayran
Journal:  Support Care Cancer       Date:  2009-05-31       Impact factor: 3.603

8.  Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial.

Authors:  Damian E Dupuy; Dawei Liu; Donna Hartfeil; Lucy Hanna; Jeffrey D Blume; Kamran Ahrar; Robert Lopez; Howard Safran; Thomas DiPetrillo
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

9.  Radiotherapy for bone pain.

Authors:  P R Needham; N P Mithal; P J Hoskin
Journal:  J R Soc Med       Date:  1994-09       Impact factor: 5.344

10.  Does kV Image Guidance for Bone Metastases Improve Pain Control?

Authors:  Ahmet S Tunceroglu; Bin Gui; Shou-En Lu; Julian Sison; Rahul Parikh; Sharad Goyal; Bruce G Haffty; Sung Kim; Salma K Jabbour
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.